DOJ is backing AbbVie in its battle to overturn a Colorado law that prohibits pharmaceutical companies from placing ...
Scoop: Cigna has acquired CarepathRx, a large pharmacy backed by private equity that dispenses prescription drugs to nearly ...
They ran through a menu of takes on biotech stock performance, M&A, Food and Drug Administration turmoil, election intrigue, ...
The order aims to shore up production of the herbicide glyphosate (better known as the active ingredient in the weed killer ...
Today, a story about the regulatory challenges behind the Neuralink hype.
FDA Commissioner Marty Makary defended the agency’s recent rejections of rare disease drugs and one of his deputies, Vinay ...
Her son Ben, she learned, had mucopolysaccharidosis (MPS) type 2, or Hunter Syndrome, one of a group of rare diseases that is ...
Thirty years after scientists demonstrated how brain implants can help rhesus monkeys move robotic limbs using only their ...
Xenon Pharmaceuticals is developing a drug for the most common type of seizure experienced by people with epilepsy. Here's ...
When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...
Vice President JD Vance announced Wednesday that the Trump administration would “temporarily halt” some Medicaid funding to ...
Pharmalittle: We’re reading about Trump’s drug-price claims, a Novo deal for obesity drugs, and more
In his State of the Union address, President Trump claimed he had brought U.S. prescription drug costs from the highest in the world to the lowest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results